Only 3.1% Americans engage in activities to prevent a diabetes diagnosis.
Read More »Lower Death Risk with SGLT2 Inhibitors in Patients with Type 2 Diabetes
It is unclear whether SGLT2i show reduction in mortality in all patients with type 2 or just in patients with type 2 diabetes with increased cardiovascular risk.
Read More »Study Explores Mechanisms Behind Cardiovascular Benefits of SGLT2 inhibitors
Researchers complete examination of class of type 2 medication.
Read More »Benefits of Obesity Management in Type 2 Diabetes
Management of obesity by dietary, pharmacologic, and surgical intervention can provide very positive results.
Read More »American College of Physicians Recommending Controversial Increase in A1c of 7% to 8%
Organization says adults with type 2 diabetes can aim for an easier-to-achieve blood sugar target than what’s been used to guide treatment in the past.
Read More »Are We Doing a Better Job of Detecting Diabetes?
While detection of type 2 diabetes for specific subgroups in the population has slightly increased, overall detection rates remain low among US adults.
Read More »Is Poor Glucose Control and High Prevalence of Obesity Expected with Early-Onset T2D?
Study shows importance of clinical consciousness and assistance with disease management in individuals who were diagnosed with type 2 diabetes prior to age 45.
Read More »Microneedle-Array Patches: An Innovative Way to Treat Type 2 Diabetes
Patch delivery system shows promise as a new developing treatment option for diabetes.
Read More »Type 2 Diabetes Can Begin 20 Years Prior to Diagnosis
Subtle elevations in fasting glucose and triglycerides associated with developing type 2 diabetes.
Read More »Impact of Age, Gender, and Diagnosis of T2D on Overall Mortality
Study conducted in Germany demonstrates all-cause mortality to be doubled in patients with both diagnosed and undiagnosed type 2 diabetes.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.